Beckerhoff R, Uhlschmid G, Furrer J, Nussberger J, Schmied U R, Vetter W J, Siegenthaler W
Eur J Pharmacol. 1975 Dec;34(2):363-7. doi: 10.1016/0014-2999(75)90263-0.
The effects of infusions of equimolar doses of Sar1-Ile8-angiotensin II and of Sar1-Ala8-angiotensin II on plasma aldosterone, plasma renin activity and arterial blood pressure were compared in normal dogs. Plasma aldosterone increased significantly after Sar1-Ile8-angiotensin II whereas it was unaffected by Sar1-Ala8-angiotensin II. Changes in blood pressure and renin activity were small without marked differences between both groups of animals. The experiments demonstrate a clear steroidogenic potency of Sar1-Ile8-angiotensin II. Therefore, Sar1-Ala8-angiotensin II should be preferred as antagonist of the action of angiotensin II in the adrenal gland.
在正常犬中比较了等摩尔剂量的Sar1-Ile8-血管紧张素II和Sar1-Ala8-血管紧张素II输注对血浆醛固酮、血浆肾素活性和动脉血压的影响。Sar1-Ile8-血管紧张素II输注后血浆醛固酮显著增加,而Sar1-Ala8-血管紧张素II对其无影响。两组动物的血压和肾素活性变化较小,无明显差异。实验证明Sar1-Ile8-血管紧张素II具有明显的促肾上腺皮质激素生成作用。因此,在肾上腺中,Sar1-Ala8-血管紧张素II应优先作为血管紧张素II作用的拮抗剂。